SPONSOR

University Health Network, Toronto

Total Trials

Recruiting

Phases

Phase 2, Phase 4, Phase 3, Phase 1, Phase 2

Conditions studied: Spinal Metastases Esophagogastric Cancer Autoimmune Hepatitis Spontaneous Intracranial Hypotension Thyroid Nodule Thyroid Cancer Metastatic Prostate Cancer Distal Radius Fractures Esophageal Cancer Histopathologically or Cytologically Confirmed Solid Tumor Who Require Palliation Radiation Therapy to a Lesion ≥5cm

University Health Network, Toronto is a clinical research sponsor with 38 registered studies on ClinicalTrials.gov, of which 38 are actively recruiting participants. Research covers conditions including Spinal Metastases, Esophagogastric Cancer, Autoimmune Hepatitis, Spontaneous Intracranial Hypotension.

The trial portfolio spans Phase 2, Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Health Network, Toronto

How many clinical trials has University Health Network, Toronto sponsored?

ClinicalMetric currently tracks 38 clinical trials sponsored by University Health Network, Toronto, of which 38 are actively recruiting participants. These trials cover conditions including Spinal Metastases, Esophagogastric Cancer, Autoimmune Hepatitis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University Health Network, Toronto research focus on?

University Health Network, Toronto clinical trials span Spinal Metastases, Esophagogastric Cancer, Autoimmune Hepatitis, Spontaneous Intracranial Hypotension, Thyroid Nodule, and additional conditions. The research pipeline includes Phase 2, Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University Health Network, Toronto clinical trial?

To participate in a University Health Network, Toronto trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Health Network, Toronto trials with current recruitment status updated daily.

University Health Network, Toronto

Frequently Asked Questions — University Health Network, Toronto

Clinical Trials by University Health Network, Toronto

Comparing SBRT to CRT in Patients With Spinal Metastases

PET-MRI Esophagus Feasibility Study

Belimumab in Autoimmune Hepatitis

Greater Occipital Nerve Block for Spontaneous Intracranial Hypotension

The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer

TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation

Tissue Collection Protocol for Gastroesophageal Cancers

Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors

Inhale and Exhale Breath Holds to Improve the Radiation Therapy Accuracy in People With Upper Abdominal Cancers

Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T

Registry for Patients Receiving Intravenous Nutrition at Home

Effect of Hi-OxSR for the Treatment of Post COVID Condition

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium

Inspiratory Muscle Training in Lung Transplant Candidates

Inspiratory Work of Breathing Before and After Extubation

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Caregivers of Patients With Advanced Cancer

Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty

Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC

PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation

HN-QUEST: A Study of Head and Neck Imaging Biomarkers

Co-Adaptation of an Digital Pain Management Program for Canadian Veterans

Study of How Safe and Effective Tarlatamab is in Brain Cancers

Improving Patient Sleep Prior to Elective Surgery

A Study of High Dose Radiation Therapy for Locally Advanced Pancreatic Cancer That Responded to Initial Chemotherapy Treatment

AI for Gastric POCUS ( Point-of-care Ultrasound)

High-Dose-Rate Brachytherapy

Immune Resistance Interrogation Study

Opioid Use Post-Discharge After Ambulatory Distal Arm Surgery

Effects of Compression Stockings in Asthma Symptoms at Night

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma

Improving Sleep for Older Adults in the Emergency Department

PRT for Chronic Low Back Pain

Efficacy of Biofeedback Training for Glaucoma

A2 to O Lung Transplants

CfDNA in Hereditary And High-risk Malignancies 2